
2024 Final Medicare Physician Fee Schedule
CMS released its final rule updating the Medicare physician fee schedule for calendar year 2024 (Final Rule).

PBMs – how influential are they?
Many of us were shocked by the news that GlaxoSmithKline (GSK) Pharmaceuticals withdrew Flovent from the U.S. market at the end of 2023.

Advocacy Council endorses Fee Schedule fix
Congress must pass legislation before the end of the year to prevent these cuts from taking effect on Jan. 1, 2024.

2024 RVUs impact allergy
Allergists are expected to experience a -1.9% reimbursement impact due to the lower 2024 conversion factor (which takes into account the 1.25% legislative incr…

Site-Neutral Payments
Lawmakers have begun to focus on one option: expanding site-neutral payments for services in off-campus Hospital Outpatient Departments.

Value-Based Care Task Force identifies opportunities for allergists
This expert group is now looking at a variety of value-based care arrangements that can benefit allergists

2023 Advocacy Council’s New Leader
Dr. Miller is a strong advocate for our specialty and was recognized for his efforts by California Senator Bob Huff.

The College’s HOD continues its mission
How can you help your colleagues’ voices to be heard? Find out what it takes to be a state delegate or a super-delegate.

Our most frequently asked USP 797 question
The Advocacy Council encourages all allergists to implement USP standards and believes an AECA is the best option for most allergy practices.








